Santalis Pharmaceuticals Announces First Subject Enrolled in Phase 2 Trial of East Indian Sandalwood Oil (EISO) in Oral Mucositis http://www.businesswire.com/news/ho...aceuticals-Announces-Subject-Enrolled-Phase-2
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game